Novus Biologicals Competitors and Similar CompaniesClear all
Genentech's competitors and similar companies include Ipsen and BioMarin Pharmaceutical.
 Genentech Genentech is a biotechnology company that discovers, develops, manufactures, and commercializes medicines. |  BioMarin Pharmaceutical BioMarin develops and provides innovative biopharmaceuticals for serious diseases and medical conditions. | ||
Founding Date | Founding Date 1976 | Founding Date 1929 | Founding Date 1997 |
Type | Type Subsidiary | Type Public | Type Public |
Tags | |||
Locations | Locations South San Francisco, US HQ Hillsboro, US Oceanside, US Portland, US South San Francisco, US South San Francisco, US South San Francisco, US see more | Locations Boulogne-Billancourt, FR HQ Algiers, DZ South Yarra, AU Wien, AT Merelbeke, BE São Paulo, BR Mississauga, CA see more | Locations San Rafael, US HQ Martínez, AR Crows Nest, AU Sao Paulo, BR Bogotá, CO Kronberg Im Taunus, DE Wanchai, HK see more |
Employees | Employees 18,077 | Employees 5,358 | Employees 3,0015% increase |
Valuation ($) | Valuation ($) N/A | Valuation ($) 10.2 b | Valuation ($) 13.3 b |
Financial | |||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) €3.7b (FY, 2025) | Revenue (est.) $3.2b (FY, 2025) |
Cost of goods | Cost of goods N/A | Cost of goods €659.1m (FY, 2025) | Cost of goods $717.4m (FY, 2025) |
Gross profit | Gross profit N/A | Gross profit €3.3b (FY, 2025) | Gross profit $2.5b (FY, 2025) |
Net income | Net income N/A | Net income €445.1m (FY, 2025) | Net income $348.9m (FY, 2025) |
Operating ⚠ | |||
Phase III Trials Products | Phase III Trials Products 41 (Jul, 2025) | Phase III Trials Products N/A | Phase III Trials Products 2 (FY, 2016) |
For sources of this data, please see the company profile
View Company Profiles
BioMarin Pharmaceutical
HQ
San Rafael, US
Employees
3,001↑ 5% increase
BioMarin develops and provides innovative biopharmaceuticals for serious diseases and medical conditions.
View company